Combating Cannabis Stigmas Through Legalization and Innovation

By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder Germany’s cannabis industry is soaring to new heights under the passage of the landmark German Medical Cannabis Act (CanG). As of April 1, cannabis is now rescheduled as a non-narcotic. Such actions…

How Germany’s Medical Market Expansion May Mitigate Canada’s Cannabis Surplus

By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder Since the legalization of adult-use sales in 2018, the Canadian cannabis market has seen rapid highs and, more recently, serious oversupply woes. As of December 2022, the country had a massive stockpile…

German Cannabis Club Rules Leak, Many Optimistic for Medical Cannabis Expansion

By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder In April 2023, German Health Minister Karl Lauterbach announced a two-pillar, scaled-down approach to adult-use cannabis legalization. The blueprint included the introduction of nonprofit associations, or cannabis clubs, that will be able…

Growth Opportunities for CannaGenetics in Germany’s Burgeoning Market

By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder In 2022, Germany made significant steps toward making adult-use cannabis legalization a reality. Last October, Germany’s Health Minister Karl Lauterbach released a cornerstone paper outlining plans for the legal sale and consumption…

New Year, New Steps Towards Adult-Use Cannabis for Germany

By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder In October 2022, Germany’s Health Minister Karl Lauterbach released a cornerstone paper outlining plans for the legal sale and consumption of cannabis in the country. While this is a big step forward…

German Adult-Use Legalization Hearings and EU Countries Collab on Cannabis: What Can We Expect Next?

September 28, 2022
Niklas Kouparanis
Europe, Germany
1 Comment

By Niklas Kouparanis Current international law, which restricts the cultivation, supply and possession of cannabis only for medical and scientific purposes, has failed to achieve its set goals. Recently, three European Union (EU) countries–Malta, Luxembourg and Germany–have come together to…

Following Five Years of Medical Cannabis, Germany is Poised to be the Adult-Use Capital of Europe

By Niklas Kouparanis On March 10, 2022, Germany celebrated the fifth anniversary of medical cannabis legalization. It has been an eventful five years with plenty of challenges and limitations to navigate, overcome and learn from. During the five-year run, Germany’s…

Legalization is a learning curve: Germany is in the driver’s seat to make adult-use a reality

With adult-use legalization in Germany officially set to be legalized by the incoming government, the country of 84 million residents is on its way to becoming the largest cannabis market in Europe–and possibly the world. The news also makes Germany…

Combating Cannabis Stigmas Through Legalization and Innovation

How Germany’s Medical Market Expansion May Mitigate Canada’s Cannabis Surplus

German Cannabis Club Rules Leak, Many Optimistic for Medical Cannabis Expansion

Growth Opportunities for CannaGenetics in Germany’s Burgeoning Market

New Year, New Steps Towards Adult-Use Cannabis for Germany

German Adult-Use Legalization Hearings and EU Countries Collab on Cannabis: What Can We Expect Next?

Following Five Years of Medical Cannabis, Germany is Poised to be the Adult-Use Capital of Europe

Legalization is a learning curve: Germany is in the driver’s seat to make adult-use a reality

Upcoming Events

CANNEXPO

ICBC Berlin 2025

MJ Unpacked Atlantic City 2025

Cannabis Drinks Expo 2025 Growing the Category